Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers
Cancer Research Communications shared a post on X about their recent paper published by Hyun Jung Lee et al.:
“Recently published:
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies, by Hyun Jung Lee et al.”
Hsieh Lab shared this post, adding:
“Her2 is expressed in a lot of cell types, but not all cell types. Implications for emerging treatments for GU cancers. Congrats to Ruben Raychaudhuri for this piece of work.”
Title: Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
Authors: Hyun Jung. Lee, Roman Gulati, Erolcan Sayar, Radhika A. Patel, Pushpa Itagi, Helen M. Richards, Thomas Persse, Sonali Arora, Ilsa Coleman, Mohamed Adil, Samantha L. Schuster, Farinaz Shokri, Jonathan L. Wright, Evan Y. Yu, Lawrence D. True, Meagan Chambers, Jessica E. Hawley, Heather H. Cheng, Michael T. Schweizer, Petros Grivas, Peter S. Nelson, R Bruce. Montgomery, Andrew C. Hsieh, Funda Vakar-Lopez, Colm Morrissey, Hung-Ming Lam, Gavin Ha, Maria S. Tretiakova, Michael C. Haffner, Ruben Raychaudhuri
You can read the Full Article on Cancer Research Communications.
More posts featuring Cancer Research Communications.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023